(Q34096365)

31 July 2017

1 reference

title

VEGF: an update on biological and therapeutic aspects (English)

1 reference

31 July 2017

Ferrara N

1

1 reference

31 July 2017

publication date

1 December 2000

1 reference

Current Opinion in Biotechnology

31 July 2017

published in

1 reference

31 July 2017

volume

11

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

617-624

1 reference

The biology of vascular endothelial growth factor

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Role of vascular endothelial growth factor in the regulation of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Signaling angiogenesis and lymphangiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Vascular endothelial growth factor is a secreted angiogenic mitogen

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Clinical applications of angiogenic growth factors and their inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Vascular endothelial growth factor (VEGF) and its receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Current biology of VEGF-B and VEGF-C.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Mechanisms of angiogenesis and arteriogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Effects of vascular endothelial growth factor on pancreatic duct cell replication and the insulin production of fetal islet-like cell clusters in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Receptors for collapsin/semaphorins.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Inducible gene targeting in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Vascular endothelial growth factor is expressed in rat corpus luteum

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Vascular endothelial growth factor is essential for corpus luteum angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Preclinical safety evaluation of rhuMAbVEGF, an antiangiogenic humanized monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Suppression of Luteal Angiogenesis in the Primate after Neutralization of Vascular Endothelial Growth Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Ovarian hyperstimulation syndrome. Report of a case with notes on pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyperstimulation syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Increased vascularization in mice overexpressing angiopoietin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

Angiopoietin-1 protects the adult vasculature against plasma leakage.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900153-1

7 January 2021

10.1016/S0958-1669(00)00153-1

Identifiers

DOI

1 reference

31 July 2017

1 reference